| Literature DB >> 26922990 |
Alana K Sterkel1, Jenna L Lorenzini1, J Scott Fites1, Kavitha Subramanian Vignesh2, Thomas D Sullivan1, Marcel Wuthrich1, Tristan Brandhorst1, Nydiaris Hernandez-Santos1, George S Deepe2, Bruce S Klein3.
Abstract
Systemic fungal infections trigger marked immune-regulatory disturbances, but the mechanisms are poorly understood. We report that the pathogenic yeast of Blastomyces dermatitidis elaborates dipeptidyl-peptidase IVA (DppIVA), a close mimic of the mammalian ectopeptidase CD26, which modulates critical aspects of hematopoiesis. We show that, like the mammalian enzyme, fungal DppIVA cleaved C-C chemokines and GM-CSF. Yeast producing DppIVA crippled the recruitment and differentiation of monocytes and prevented phagocyte activation and ROS production. Silencing fungal DppIVA gene expression curtailed virulence and restored recruitment of CCR2(+) monocytes, generation of TipDC, and phagocyte killing of yeast. Pharmacological blockade of DppIVA restored leukocyte effector functions and stemmed infection, while addition of recombinant DppIVA to gene-silenced yeast enabled them to evade leukocyte defense. Thus, fungal DppIVA mediates immune-regulatory disturbances that underlie invasive fungal disease. These findings reveal a form of molecular piracy by a broadly conserved aminopeptidase during disease pathogenesis.Entities:
Keywords: DppIV; TipDCs; fungal; macrophages; neutrophils
Mesh:
Substances:
Year: 2016 PMID: 26922990 PMCID: PMC5088612 DOI: 10.1016/j.chom.2016.02.001
Source DB: PubMed Journal: Cell Host Microbe ISSN: 1931-3128 Impact factor: 31.316